BDH-Klinik Hessisch Oldendorf
Hessisch Oldendorf, Lower Saxony, 31840, Germany
Location status: Recruiting
Location contact
Melanie Boltzmann, PhD
CONTACT
Simone B. Jenner
CONTACT
NCT Number: NCT07456020
Accurately determining the level of consciousness in patients with severe brain injury is essential for treatment planning, prognosis, and ethical decision-making. Clinically, levels of consciousness are differentiated into coma, Unresponsive Wakefulness Syndrome (UWS), and Minimally Conscious State (MCS) based on behavioral signs. Although behavioral assessment is considered the clinical gold standard, it is prone to misclassification. Research has shown that a substantial proportion of patients initially diagnosed with UWS may actually show signs of minimal consciousness, which is associated with better cognitive abilities and a more favorable prognosis.
The Coma Recovery Scale-Revised (CRS-R) is internationally recommended for diagnosing disorders of consciousness, but it is time-consuming and not free from diagnostic error. Repeated assessments can significantly improve diagnostic accuracy. To enhance feasibility in routine clinical practice, a shorter and more time-efficient assessment tool, the Simplified Evaluation of CONsciousness Disorders (SECONDs), was developed. This scale focuses on the behavioral signs most strongly associated with MCS and uses optimized testing procedures while maintaining high diagnostic accuracy.
The aim of this study is to further evaluate diagnostic approaches for assessing consciousness in patients with severe brain injury and to improve the reliability and clinical applicability of these assessments.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Hessisch Oldendorf, Lower Saxony, 31840, Germany
Location status: Recruiting
Melanie Boltzmann, PhD
CONTACT
Simone B. Jenner
CONTACT
This prospective observational study is designed to evaluate the clinical utility and diagnostic performance of the Simplified Evaluation of CONsciousness Disorders (SECONDs) in a neurological rehabilitation setting. The study aims to assess whether the implementation of SECONDs improves diagnostic accuracy in patients with disorders of consciousness during the subacute phase after severe acquired brain injury.
Participants will undergo structured behavioral assessment using SECONDs as part of the study protocol. Diagnostic classifications derived from SECONDs will be analyzed with regard to their internal consistency and clinical plausibility within the rehabilitation context.
To examine prognostic validity, functional outcome will be assessed 12 months after the initial evaluation. Follow-up data will be collected through structured telephone interviews with relatives or legal representatives. Functional status will be systematically documented in order to determine the predictive value of SECONDs classifications for long-term clinically relevant outcomes.
The study seeks to contribute to optimizing diagnostic procedures in disorders of consciousness and to strengthen the evidence base for time-efficient behavioral assessment tools in routine neurorehabilitation practice.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Simplified Evaluation of CONsciousness Disorders (SECONDs) is a structured behavioral assessment tool designed for the rapid evaluation of patients with disorders of consciousness.
The Coma Recovery Scale-Revised (CRS-R) is a standardized behavioral assessment tool used to evaluate the level of consciousness in patients with severe brain injury. It consists of six subscales assessing auditory, visual, motor, oromotor/verbal, communication, and arousal functions.
Time frame: 6-8 days after admission to neurological rehabilitation
Categorical agreement in clinical classification of level of consciousness (Unresponsive Wakefulness Syndrome [UWS], Minimally Conscious State [MCS], Emerged from Minimally Conscious State [eMCS], No Disorder of Consciousness [non-DoC]) between the Simplified Evaluation of CONsciousness Disorders (SECONDs) and the Coma Recovery Scale-Revised (CRS-R).
Time frame: 6-8 days after admission to neurological rehabilitation
Rate of diagnostic reclassification following repeated behavioral assessment on two consecutive days in patients initially diagnosed with Unresponsive Wakefulness Syndrome (UWS). Misdiagnosis rate is defined as the proportion of patients whose level of consciousness is reclassified into a different diagnostic category (e.g., from UWS to Minimally Conscious State [MCS]) upon repeat measurement.
Time frame: 12 months after admission.
Predictive value of baseline classification using the Simplified Evaluation of CONsciousness Disorders (SECONDs; ; Range: 0-8) for functional outcome at 12 months after admission, as measured by the Glasgow Outcome Scale-Extended (GOSE; Range: 1-8).
Time frame: 6-8 days after admission to neurological rehabilitation
Assessment of clinical feasibility of SECONDs in a neurological rehabilitation setting, including test completion rate, administration time per assessment, and occurrence of premature test termination or technical/practical difficulties.
Contact information is provided by the study sponsor or research team.
Melanie Boltzmann, PhD
CONTACT
Simone B. Jenner
CONTACT
BDH-Klinik Hessisch Oldendorf
Other
Assessment of Consciousness After Severe Brain Injury: Comparison of CRS-R and SECONDs
Acronym: AssessConsc
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07485361
Brain Damage, Chronic, Brain Diseases
Los Angeles, California, United States
View Trial DetailsNCT07277309
Brain Damage, Chronic, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06939348
Brain Damage, Chronic, Brain Diseases
Los Angeles, California, United States
View Trial DetailsNCT07694258
Consciousness Disorders, Disorders of Consciousness
Toronto, Ontario, Canada
View Trial Details